Inclusion Criteria:  Willing and able to provide written informed consent Negative pregnancy test at screening and prior to dosing Minimum body weight of 50 kg and body mass index (BMI) of 18-32 kg/m2  Exclusion Criteria:  Use of other investigational drugs within 28 days of dosing Positive pregnancy test Abuse of alcohol or drugs Other clinically significant medical conditions or laboratory abnormalities